A Case of Primary Pulmonary Meningioma With Genetic Characterization and Literature Review.

IF 0.6 Q4 ONCOLOGY
Case Reports in Oncological Medicine Pub Date : 2025-09-30 eCollection Date: 2025-01-01 DOI:10.1155/crom/6077936
Zachary Braunstein, Jesse Pullen, Konstantin Shilo, Andres Madrigal, Gabriel Tinoco
{"title":"A Case of Primary Pulmonary Meningioma With Genetic Characterization and Literature Review.","authors":"Zachary Braunstein, Jesse Pullen, Konstantin Shilo, Andres Madrigal, Gabriel Tinoco","doi":"10.1155/crom/6077936","DOIUrl":null,"url":null,"abstract":"<p><p>Primary pulmonary meningiomas (PPMs) are exceptionally rare tumors, accounting for a small fraction of ectopic meningiomas found outside the central nervous system (CNS). These tumors are typically benign, with only 5%-8% being malignant. Since the first reported case in 1982, fewer than 100 cases have been documented. We report a unique case of PPM in a 58-year-old male detected incidentally during lung cancer screening. Histopathological and immunohistochemical (IHC) analysis confirmed the diagnosis, and next-generation sequencing (NGS) revealed a Neurofibromatosis Type 2 (NF2) inactivating mutation and a likely subclonal PALB2 mutation-findings not commonly reported in the PPM literature. Our comprehensive review of 70 reported cases reveals a female predominance, asymptomatic presentation in most cases, and strong IHC positivity for EMA, PR, and vimentin. Malignant cases tended to be larger and more symptomatic. Our case highlights the value of molecular profiling in differentiating PPMs from other pulmonary neoplasms and CNS metastases. Given the emerging role of NGS in identifying tumor-specific mutations, further exploration of the genetic landscape of PPMs is warranted. Recognition of NF2 mutations as potential drivers may open new avenues for targeted therapies and long-term monitoring strategies in affected individuals.</p>","PeriodicalId":9636,"journal":{"name":"Case Reports in Oncological Medicine","volume":"2025 ","pages":"6077936"},"PeriodicalIF":0.6000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503964/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Oncological Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/crom/6077936","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Primary pulmonary meningiomas (PPMs) are exceptionally rare tumors, accounting for a small fraction of ectopic meningiomas found outside the central nervous system (CNS). These tumors are typically benign, with only 5%-8% being malignant. Since the first reported case in 1982, fewer than 100 cases have been documented. We report a unique case of PPM in a 58-year-old male detected incidentally during lung cancer screening. Histopathological and immunohistochemical (IHC) analysis confirmed the diagnosis, and next-generation sequencing (NGS) revealed a Neurofibromatosis Type 2 (NF2) inactivating mutation and a likely subclonal PALB2 mutation-findings not commonly reported in the PPM literature. Our comprehensive review of 70 reported cases reveals a female predominance, asymptomatic presentation in most cases, and strong IHC positivity for EMA, PR, and vimentin. Malignant cases tended to be larger and more symptomatic. Our case highlights the value of molecular profiling in differentiating PPMs from other pulmonary neoplasms and CNS metastases. Given the emerging role of NGS in identifying tumor-specific mutations, further exploration of the genetic landscape of PPMs is warranted. Recognition of NF2 mutations as potential drivers may open new avenues for targeted therapies and long-term monitoring strategies in affected individuals.

Abstract Image

Abstract Image

Abstract Image

原发性肺脑膜瘤1例遗传特征及文献复习。
原发性肺脑膜瘤(PPMs)是一种非常罕见的肿瘤,在中枢神经系统(CNS)外发现的异位脑膜瘤中占一小部分。这些肿瘤通常是良性的,只有5%-8%是恶性的。自1982年报告首例病例以来,记录在案的病例不到100例。我们报告一个独特的病例PPM在一个58岁的男性偶然发现在肺癌筛查。组织病理学和免疫组化(IHC)分析证实了诊断,下一代测序(NGS)显示2型神经纤维瘤病(NF2)失活突变和可能的亚克隆PALB2突变-这些发现在PPM文献中不常见。我们对70例报告病例的综合回顾显示,女性占优势,大多数病例无症状表现,并且EMA, PR和vimentin的免疫组化阳性。恶性病例往往更大,更有症状。我们的病例强调了分子谱分析在鉴别PPMs与其他肺肿瘤和中枢神经系统转移中的价值。鉴于NGS在识别肿瘤特异性突变中的新兴作用,PPMs的遗传景观的进一步探索是有必要的。认识到NF2突变是潜在的驱动因素,可能为受影响个体的靶向治疗和长期监测策略开辟新的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
11
审稿时长
16 weeks
期刊介绍: Case Reports in Oncological Medicine is a peer-reviewed, Open Access journal that publishes case reports and case series related to breast cancer, lung cancer, gastrointestinal cancer, skin cancer, head and neck cancer, paediatric oncology, neurooncology as well as genitourinary cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书